CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Stock Cash Flow
TSX-V:CYTO - TSX Venture Exchange - CA2328211081 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -7.91M | -4.64M | -3.68M | -3.24M | |||
| Depreciation Amortization | 708.20K | 512.80K | 364.60K | 295.80K | |||
| Change In Working Capital | -478.90K | 432.10K | -75.30K | -147.00K | |||
| Interest Paid | N/A | 4.60K | 20.10K | 30.50K | |||
| Taxes Paid | N/A | 0.00 | N/A | N/A | |||
| Other non cash items | 3.08M | 832.10K | 449.50K | 54.30K | |||
| OPERATING CASH FLOW | -4.61M | -2.86M | -2.94M | -3.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -1.24M | -162.10K | -380.80K | -333.10K | |||
| Other Investing Activity | N/A | -2.46M | N/A | N/A | |||
| INVESTING CASH FLOW | 4.15M | -2.62M | -380.80K | -333.10K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | -355.00K | -186.50K | -147.90K | -130.60K | |||
| Stock Issued/Repurchased | 2.76M | 994.80K | 876.10K | 6.81M | |||
| Other Financing Activity | -71.40K | 2.45M | 0.00 | -91.30K | |||
| FINANCING CASH FLOW | 2.34M | 3.26M | 728.30K | 6.58M | |||
| CHANGE IN CASH | 1.88M | -2.21M | -2.60M | 3.22M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -4.61M | -2.86M | -2.94M | -3.03M | |||
| Capital Expenditure | -1.24M | -162.10K | -380.80K | -333.10K | |||
| FREE CASH FLOW | -5.85M | -3.02M | -3.32M | -3.37M | |||
All data in CAD